If this scenario were to play out, it could be very bad news for the market. Here’s why investors need to have this big risk on their radar now.
Read MoreIf this week is any indication, I think it’s a good bet to say that volatility could be the most accurate description of market activity for the next few weeks. Late in Tuesday’s trading session, all of the major indices turned sharply lower after President Trump tweeted an order to Republicans to halt all talks […]
Read MorePlus, President Trump called off stimulus negotiations, Eli Lilly submitted a request to the FDA for emergency use authorization for its experimental COVID-19 antibody treatment, and GE got a Wells notice from the SEC.
Read MorePlus, Trump is back at the White House, House Speaker Pelosi and Treasury Secretary Mnuchin will resume stimulus negotiations today, and Apple announced a new product launch event for October 13 where it is expected to unveil new iPhone models.
Read MorePlus, AMC shares are down as movie theaters close with no big releases until the end of this year, Bristol-Myers Squibb is buying MyoKardia, and Nvidia is building a $52 million supercomputer for Cambridge.
Read MorePlus, nonfarm payrolls for September came in lower than expected, stimulus talks are in limbo, and Tesla delivered more vehicles than expected in the third quarter.
Read MoreNo matter what the market or economy is doing at any given time – bull market, bear market, expansion, contraction, or stagnation – one of the things that makes it compelling is the reality that there is always a new opportunity to take advantage of. That doesn’t mean that you can ignore broad market conditions […]
Read MorePlus, initial jobless claims were lower than expected, AstraZeneca shares are down after the FDA said it’s expanding its inquiry into the serious illness of a participant in its COVID vaccine trial, and the CEOs of Facebook, Google, and Twitter will be subpoenaed for testimony by the Senate Commerce Committee.
Read MoreIf you think strictly about price performance and what the price of a stock is now relative to where it was in the past – in particular, relative to where it was on a pre-pandemic basis – it’s pretty easy to understand why so much attention is being paid to Tech stocks that make remote […]
Read MorePlus, several blue-chip companies announced tens of thousands of job cuts, Moderna and Regeneron are up on positive coronavirus drug news, and two software companies went public through direct listings this morning.
Read MoreThe market’s uncertainty over the last couple of weeks appears to have raised the spectre of increasing downside risk, even as the market this week has managed to reclaim a portion of the drop to correction territory that started earlier this month. It is clear that while the stock market pushed past its pre-pandemic highs […]
Read MorePlus, global coronavirus cases surpassed 1 million, JPMorgan will pay $920 million to resolve probes related to ‘spoofing’ by its traders, and Nikola shares are down again this morning on assault allegations against former Chairman Milton.
Read MorePlus, Goldman Sachs said fears that a delayed U.S. election result could upend the stock market are overblown, Novavax entered a late stage trial for its coronavirus vaccine candidate, and Amazon announced two new Fire TV sticks.
Read More“Coronavirus exhaustion” may not be a real term – but I do believe it’s a real thing. Over the last few months, it seems that there is real fatigue about hearing more news about COVID-19, vaccine trials, or the importance of hand washing and mask wearing. That comes in the face of increasing infection rates […]
Read MorePlus, President Trump refused to commit to a peaceful transition of power should he lose the November election, last week’s initial jobless claims were higher than expected, and United Airlines is about to start offering rapid coronavirus tests to some fliers to Hawaii.
Read More